A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis

Conditions: Multiple Sclerosis (MS)

Interventions: Drug: elezanumab; Drug: placebo

Sponsors: AbbVie

Completed

Clinical Trials online